NCT06024564终止不适用
Sonu Real-World Use Clinical Study to Treat Moderate to Severe Nasal Congestion
Third Wave Therapeutics2 个研究点 分布在 1 个国家目标入组 121 人开始时间: 2023年8月8日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 终止
- 发起方
- 入组人数
- 121
- 试验地点
- 2
- 主要终点
- Weekly Utilization-Frequency
研究概览
简要总结
Real world utilization of Acoustic Resonance Therapy for symptoms of Nasal Congestion
详细描述
This is an interventional study designed to gather data on real world utilization of Acoustic Resonance Therapy for treating moderate to severe nasal congestion
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •18 years of age and older
- •Present with symptoms of chronic nasal congestion
- •Have a 24 hour reflective nasal congestion subscore of the TNSS of 2 or more on a 0 to 3 scale at the time of screening
排除标准
- •Head, nasal or sinus surgery within 3 months
- •Pregnancy
结局指标
主要结局
Weekly Utilization-Frequency
时间窗: 90 days
Weekly utilization of Sonu treatment, measured as the frequency or number of times used per week
Weekly Utilization-Duration
时间窗: 90 days
Weekly utilization of Sonu treatment, measured as the duration of treatment received per week
次要结局
- Total Nasal Symptom Score (TNSS)(90 days)
- Asthma Control(90 days)
研究者
研究点 (2)
Loading locations...
相似试验
已完成
不适用
Sonu Nasal Congestion Relief Study in Patients Suffering From Moderate to Severe Nasal CongestionNasal Congestion and InflammationsNCT05821842Third Wave Therapeutics52
已完成
不适用
The Safety and Efficacy of a SinuSonic InterventionNasal CongestionNCT03906968Medical University of South Carolina40
已完成
4 期
To Determine if Diphenhydramine Works for Nasal Congestion at Two Different DosesNasal CongestionNCT00648973Johnson & Johnson Consumer and Personal Products Worldwide1,021
已完成
4 期
Otrivine: Quality of Life (QoL) Impact in a Real-World SettingCommon ColdNCT05556148HALEON136
已完成
不适用
A User Study of the Soniflow System for Nasal Congestion ReliefNasal CongestionNCT04910139Third Wave Therapeutics50